{"url":"https://lda.senate.gov/api/v1/filings/d92661fe-8974-4d69-8e27-44f14f032d76/","filing_uuid":"d92661fe-8974-4d69-8e27-44f14f032d76","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2021,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d92661fe-8974-4d69-8e27-44f14f032d76/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Nick Kolovos","dt_posted":"2021-04-20T23:56:52.437000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1440 G Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401103952,"url":"https://lda.senate.gov/api/v1/registrants/401103952/","house_registrant_id":null,"name":"RIVENDELL GROUP LLP","description":"Law Firm","address_1":"1440 G Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICK KOLOVOS","contact_telephone":"+1 202-280-3545","dt_updated":"2026-01-30T10:53:00.159862-05:00"},"client":{"id":200473,"url":"https://lda.senate.gov/api/v1/clients/200473/","client_id":24,"name":"GENENTECH","general_description":"Biotechnology company","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing, including International Pricing Index and Most Favored Nation proposals; issues related to Medicare and Medicaid coverage and reimbursement; 340B drug discount programs; legislation related to preparedness and response to COVID.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63704,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"KOLOVOS","suffix":null,"suffix_display":null},"covered_position":"LA and Counsel, Rep. Anna Eshoo","new":false},{"lobbyist":{"id":147260,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"LAWRENCE","last_name":"BERZOK","suffix":null,"suffix_display":null},"covered_position":"LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing, including International Pricing Index and Most Favored Nation proposals; drug pricing; 340B.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63704,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"KOLOVOS","suffix":null,"suffix_display":null},"covered_position":"LA and Counsel, Rep. Anna Eshoo","new":false},{"lobbyist":{"id":147260,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"LAWRENCE","last_name":"BERZOK","suffix":null,"suffix_display":null},"covered_position":"LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}